Fig. 1
Overall survival of 100 patients with primary myelodysplastic syndromes and either normal or monosomal karyotype, stratified by the presence or absence of TP53 mutations
Fig. 1 | Blood Cancer Journal
Overall survival of 100 patients with primary myelodysplastic syndromes and either normal or monosomal karyotype, stratified by the presence or absence of TP53 mutations
